Press contact
GenoScreen - Service Communication
Tel. +33(0) 362 263 772
This email address is being protected from spambots. You need JavaScript enabled to view it.
- 18/10/2022 : GenoScreen and Illumina Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis ENG
- 30/03/2021: Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
ENG - 24/03/2021: Deeplex® Myc-TB, a breakthrough innovation to effectively fight tuberculosis FR ENG
- 17/11/2020: A microbial signature in indoor air associated with severe asthma FR ENG
- 05/11/2020: Number of new cases in contacts of leprosy patients decreases after dose of antibiotic FR ENG
- 02/11/2020: Publication of the first comprehensive performance evaluation of the "Deeplex® Myc-TB" test for the prediction of tuberculosis antibiotic resistance. FR ENG
- 09/06/2020: Tuberculosis: discovery of an ancestral lineage in the African Great Lakes region FR ENG
- 24/03/2020: GenoScreen launches a rapid, effective diagnostic kit, to combat tuberculosis antibiotic resistance FR ENG
- 03/03/2020: (French) Grippe : lutter contre les surinfections bactériennes grâce au microbiote FR
- 28/01/2019: GenoScreen finalizes a €1 million fundraising campaign to continue its international expansion - FR - ENG
- 25/10/2018: A major advance in the fight against multidrug-resistant tuberculosis - FR - ENG